Seqvera
Seqvera provides solutions for design, development, testing, and validation of biomaterials, medical devices, and other products, including advanced methods and AI-free data analysis. They focus on innovative, patented methods called BEST (Biomaterials Enhanced Simulation Testing) to address challenges in evaluation, analysis, and validation, aiming to improve clinical relevancy, reduce costs, and accelerate market readiness.
Industries
Nr. of Employees
small (1-50)
Seqvera
Terkko Health Hub - Building 14, Helsinki University Central Hospital area, Haartmaninkatu 4, FIN-00290 Helsinki, Finland
Patents
Method for measurement and model-free evaluation of injectable biomaterials properties
US-10809171-B2
View DetailsIn vitro method for measurement and model-free evaluation of time-invariant biomaterials functions
US-10379106-B2
View Details
Method for measurement and model-free evaluation of injectable biomaterials properties
US-10809171-B2
View DetailsIn vitro method for measurement and model-free evaluation of time-invariant biomaterials functions
US-10379106-B2
View DetailsProducts
Patented analytical methods for biomaterials testing
Patented experimental and analytical approaches for extractive, model-free characterization of injectability, transport properties and invariant material descriptors used to optimize biomaterials and devices.
Patented analytical methods for biomaterials testing
Patented experimental and analytical approaches for extractive, model-free characterization of injectability, transport properties and invariant material descriptors used to optimize biomaterials and devices.
Services
Design and execution of coherent, application-relevant in vitro experiments for biomaterials, scaffolds, implants and medical device components to extract clinically relevant property data.
Post-processing of experimental readouts using patented idempotent algorithms to produce invariant descriptors, enable predictive behavior models and reprocess retrospective datasets.
Preparation of experimental evidence and analysis outputs suitable for regulatory compliance (e.g., MDR Annex I) and for integration into quality management system documentation and risk assessments.
Design and execution of coherent, application-relevant in vitro experiments for biomaterials, scaffolds, implants and medical device components to extract clinically relevant property data.
Post-processing of experimental readouts using patented idempotent algorithms to produce invariant descriptors, enable predictive behavior models and reprocess retrospective datasets.
Preparation of experimental evidence and analysis outputs suitable for regulatory compliance (e.g., MDR Annex I) and for integration into quality management system documentation and risk assessments.
Expertise Areas
- Biomaterials testing and characterization
- Medical device testing and validation
- Tissue engineering and scaffold evaluation
- Injectable and hydrogel characterization
Key Technologies
- Idempotent model-free analysis algorithms
- Physiologically relevant in vitro testing
- Drug transport signature (DTS) analysis
- Injectability testing methods